688076 Jiangsu Sinopep-Allsino Biopharmaceutical
- 57.03
- -0.46-0.80%
Jiangsu Sinopep-Allsino Biopharmaceutical News
Legal Opinion of Guohao Law Firm (Hangzhou) on the 2024 Second Extraordinary General Meeting of Shareholders of Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd.
Nootech: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Nootech: Nootech Biotech: 2024 Second Extraordinary General Meeting of Shareholders Meeting Information
Nootech: 2024 Second Extraordinary General Meeting of Shareholders Meeting Information
Notice from China Chengxin International Concerning Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd. and one of its actual controllers receiving a notice of filing a case from the China Securities Regulatory Commission
Nootech: Announcement on cumulative new loans
Nootech Investor Relations Activity Record Form (2024-004)
Nootai Biotech: Notice on the receipt by the company and one of the actual controllers of the case filing notice from the China Securities Regulatory Commission
Nootech Biotech: Announcement on the receipt by the company and one of the actual controllers of the case filing notice from the China Securities Regulatory Commission
Nootech: Board of Directors Rules of Procedure
Nootech: Supervisory Board Rules of Procedure
Nootech: Shareholders\' Meeting Rules of Procedure
Nootech: Articles of Association
Nootech: Announcement on amending the “Articles of Association”
Nootech: Third quarter report 2024
Nootech Biotech: Announcement of Resolutions of the 20th Meeting of the 3rd Supervisory Board
Nortel Biotech: Announcement on Renewal of Accounting Firm
Nootech: Notice on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Nootai Biotech: Announcement on holding the 2024 semi-annual and third quarter results briefing
Nootech: Announcement on holding the 2024 semi-annual and third quarter results briefing
Analysis
Price Target
No Data
No Data